Delivery Order SPE2DB22D9225-SPE2DB22FR8EP
- Not listed
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-one thousand five hundred fifty-six dollars and seventy-five cents to DMS Pharmaceutical Group Incorporated. The order is for one hundred twenty capsules of XTANDI, a forty milligram prostate cancer medication. Performance will take place in Park Ridge, Illinois over a two-day period from September twenty-first through September twenty-second of twenty twenty-three. The Defense Logistics Agency supports...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-five thousand seventeen dollars and fifty-four cents ($25,017.54) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) tablets of XTANDI 40 MG for prostate cancer treatment. The single order is for product delivery to a facility in Park Ridge, Illinois by June 23, 2023 with performance beginning on June 22, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-five thousand nine hundred twenty-nine dollars to DMS Pharmaceutical Group Incorporated. The order is for four hundred fifty-five thousand seven hundred seventy-eight capsules of XTANDI, a prostate cancer medication, to be delivered to a location in Park Ridge, Illinois. Performance will take place between July 13th and 14th of 2022. The Defense Logistics Agency supports Department of Defense procurement...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-four thousand four hundred ninety dollars and eighty cents ($34,490.80) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG for prostate cancer treatment. The place of performance is Park Ridge, Illinois, and the period of performance is one day from June 29, 2023 to June 30, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at four thousand three hundred eleven dollars and thirty-five cents ($4,311.35) to DMS Pharmaceutical Group Inc. The order is for one hundred twenty (120) capsules of the prostate cancer drug XTANDI at forty (40) milligrams per capsule. Performance will take place at the prime contractor's facility located at Park Ridge, Illinois from August 22,...
- The Defense Logistics Agency (DOD) awarded a delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. as the prime contractor. The firm fixed price order is for the delivery of 120 capsules of XTANDI 40 MG to a facility located in Park Ridge, Illinois. The period of performance is limited to a single day, running from August 14, 2023 to August 15, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with a larger...
- The Defense Logistics Agency awarded a $17,245.40 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 mg for prostate cancer treatment. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Park Ridge, Illinois from September 1st through September 5th, 2023. No set aside designation or subcontractors were identified....
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at twenty-five thousand, eight hundred sixty-eight dollars and ten cents ($25,868.10) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for one hundred twenty (120) capsules of XTANDI 40 MG, to be delivered to the prime contractor's facility in Park Ridge by August 16, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports...
- The Defense Logistics Agency (DOD) awarded a $25,868.10 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of 120 capsules of XTANDI 40 MG CAPSULE to be delivered to Park Ridge, Illinois. As a prime contractor supporting DLA's medical supply needs, DMS Pharmaceutical will provide 120 capsules of the prostate cancer drug between August 29-30, 2023. No subcontractors or set aside designations were specified. This delivery order was issued against an existing DLA...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at four thousand three hundred eleven dollars and thirty-five cents ($4,311.35) to DMS Pharmaceutical Group Incorporated. The order is for one hundred twenty (120) capsules of the pharmaceutical product XTANDI 40 MG to be delivered to a facility located in Park Ridge, Illinois by July 31, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency supports...
- SPE2DB22D9225Indefinite Delivery Contract
- SPE2DB22D9225-SPE2DB22FR8EPDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-five thousand nine hundred twenty-nine dollars to DMS Pharmaceutical Group Inc. to supply one hundred twenty capsules of XTANDI, a forty milligram prostate cancer medication. The single order is for product delivery to a facility in Park Ridge, Illinois, with performance required between August 30th and 31st, 2022. No additional details were provided regarding the prime contractor, major subcontractors, or context on Defense Logistics Agency programs. The brief period of performance and pharmaceutical product description suggest this delivery order was placed under a pre-existing Prime Vendor or similar indefinite-delivery/indefinite-quantity contract vehicle managed by the agency to support medical supply needs within the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 8/30/22 |